SEC Form 4 · accession 0000921895-16-004967
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2016 | S | 33,619 | $1.90 | D | 5,155,986 | D |
Table II — derivative securities
No Table II lines on this filing.